2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T525e,

Summary Table

Category	Details
Risk Factors	Children aged 1-5 in endemic regions (sub-Saharan Africa, Middle East, South Asia), overcrowding, poor facial hygiene, limited access to clean water, exposure to eye-seeking flies (Musca sorbens)
Etiology	Chlamydia trachomatis serotypes A, B, Ba, and C (obligate intracellular bacterium)
Patient Presentation	Chronic follicular conjunctivitis progressing over years to eyelid scarring and visual impairment; recurrent episodes of red, irritated eyes with mucopurulent discharge in children
Classic Physical Exam	Follicles on the upper tarsal conjunctiva, papillary hypertrophy, Herbert pits (limbal scarring), entropion with trichiasis (inward-turning lashes abrading the cornea), corneal pannus and opacification
Key Diagnostic Results	Clinical diagnosis using the WHO simplified grading system; Giemsa stain showing basophilic intracytoplasmic inclusion bodies; nucleic acid amplification test (NAAT) for confirmation
Management	SAFE strategy (Surgery for trichiasis, Antibiotics, Facial cleanliness, Environmental improvement); single-dose oral azithromycin (20 mg/kg) or topical tetracycline eye ointment for 6 weeks
Keywords	"Follicular conjunctivitis," "upper tarsal plate," "Herbert pits," "entropion/trichiasis," "pannus," "SAFE strategy," "leading infectious cause of blindness," "Chlamydia trachomatis serotypes A-C"

1. Pathophysiology

Trachoma is caused by repeated conjunctival infection with Chlamydia trachomatis serotypes A, B, Ba, and C. These serotypes are distinct from those causing urogenital chlamydial disease (D-K) and lymphogranuloma venereum (L1-L3). The organism is an obligate intracellular bacterium that targets conjunctival epithelial cells, where it undergoes its characteristic biphasic life cycle: the elementary body (infectious, extracellular form) attaches to and enters the cell, then converts into a reticulate body (metabolically active, replicating form) within a membrane-bound inclusion. After replication, reticulate bodies condense back into elementary bodies and are released upon cell lysis, perpetuating the cycle.

The disease does not cause blindness through a single infection. Rather, it is the result of repeated reinfections over years, typically beginning in early childhood. Each episode of active infection triggers a type IV hypersensitivity response (cell-mediated immunity) in the conjunctiva, predominantly involving CD4+ T cells and macrophages. This chronic inflammatory infiltrate is what produces the characteristic lymphoid follicles visible on the upper tarsal conjunctiva. The follicles represent organized collections of lymphocytes and are the hallmark of active trachoma.

Over time, the repeated cycles of infection and immune-mediated inflammation lead to progressive subepithelial fibrosis of the tarsal conjunctiva. This scarring contracts the tarsal plate, causing the eyelid margin to rotate inward, a condition known as entropion. Once entropion develops, the eyelashes are directed against the corneal surface, a finding called trichiasis. The constant mechanical abrasion of lashes on the cornea results in corneal epithelial damage, secondary bacterial infection, corneal pannus (fibrovascular ingrowth), and ultimately corneal opacification, which is the direct cause of irreversible blindness.

This progression from active infection to blindness typically spans decades, which is why active disease peaks in children (ages 1-5) but blindness predominantly affects adults (over age 40), particularly women, who have higher rates of exposure through close contact with infected children.

2. Classification and Clinical Manifestation

The WHO simplified trachoma grading system is the standard classification used in clinical practice and is highly testable:

WHO Grade	Name	Clinical Findings	Significance
TF	Trachomatous Inflammation, Follicular	Five or more follicles (each at least 0.5 mm) on the upper tarsal conjunctiva	Indicates active infection; most common in young children
TI	Trachomatous Inflammation, Intense	Pronounced inflammatory thickening of the upper tarsal conjunctiva obscuring more than half of the deep tarsal vessels	Indicates severe active disease with higher risk of scarring
TS	Trachomatous Scarring	White fibrotic bands or sheets visible in the tarsal conjunctiva	Indicates cumulative cicatricial damage from repeated infections
TT	Trachomatous Trichiasis	At least one eyelash touching the globe, or evidence of recent epilation	Indicates mechanical corneal damage is occurring; surgical intervention required
CO	Corneal Opacity	Corneal opacity overlying at least part of the pupillary margin	Indicates visual impairment or blindness; end-stage disease

The key clinical concept is that TF and TI represent active, infectious disease (targeted by antibiotics and hygiene measures), while TS, TT, and CO represent the cicatricial sequelae (requiring surgical intervention for TT). A patient can have both active inflammation and scarring simultaneously.

Herbert pits are another classic finding worth highlighting. These are small depressions or pits at the superior limbus (the junction of cornea and sclera) that represent resolved limbal follicles. They are considered pathognomonic for prior trachoma and are frequently described in vignettes as a clue to the diagnosis.

3. Diagnostic Workup

Test	Role	Key Findings
Clinical examination (WHO grading)	Best initial test and primary diagnostic method	Follicles and/or papillary inflammation on the upper tarsal conjunctiva upon eyelid eversion
Giemsa stain of conjunctival scraping	Supportive test	Basophilic intracytoplasmic inclusion bodies within epithelial cells
Nucleic acid amplification test (NAAT/PCR)	Most accurate/confirmatory test	Detection of C. trachomatis DNA; highest sensitivity and specificity
Direct fluorescent antibody (DFA)	Alternative confirmatory test	Fluorescent-labeled monoclonal antibodies bind to chlamydial elementary bodies
Cell culture (McCoy cells)	Historical gold standard (rarely used)	Isolation of organism; highest specificity but low sensitivity and technically demanding

Trachoma is primarily a clinical diagnosis, especially in endemic settings where laboratory resources are limited. The WHO simplified grading system was designed precisely for this purpose: a trained health worker everts the upper eyelid and examines the tarsal conjunctiva for follicles, inflammation, and scarring. No special equipment beyond a magnifying loupe and adequate light is required. In an exam vignette, the description of follicles on the everted upper tarsal plate in a child from an endemic region is sufficient to establish the diagnosis.

When laboratory confirmation is needed, Giemsa staining of conjunctival epithelial scrapings can reveal the characteristic basophilic intracytoplasmic inclusion bodies, which represent the chlamydial inclusions within host cells. However, sensitivity is limited, particularly in chronic or low-grade infections.

NAAT (PCR) is the most accurate test available, offering the highest sensitivity and specificity for detecting C. trachomatis in conjunctival swabs. It is used primarily in research, epidemiologic surveys, and when clinical diagnosis is uncertain. If a question asks for the "most accurate" or "confirmatory" test, NAAT is the answer.

An important distinction to remember: serology is not useful for diagnosing active trachoma. Because C. trachomatis infections are so common (including urogenital serotypes), serum antibodies are not specific enough to confirm ocular disease with trachoma-associated serotypes.

4. Management and Treatment

Intervention	Details	Indication
Surgery	Bilamellar tarsal rotation procedure	Trachomatous trichiasis (TT) to prevent corneal damage
Antibiotics (oral)	Azithromycin 20 mg/kg single dose (max 1 g)	Community-wide mass drug administration when TF prevalence exceeds 10% in children aged 1-9
Antibiotics (topical)	Tetracycline 1% eye ointment twice daily for 6 weeks	Alternative when oral azithromycin is unavailable
Facial cleanliness	Promotion of face-washing, especially in children	Reduces ocular and nasal discharge that facilitates transmission
Environmental improvement	Improved sanitation, water supply, fly control, reduced household crowding	Addresses the root conditions that sustain endemic transmission

The cornerstone of trachoma control is the SAFE strategy, endorsed by the WHO as an integrated public health approach. Each letter represents one pillar, and all four must be implemented together for elimination to succeed.

Surgery is indicated for patients with trachomatous trichiasis (stage TT). The procedure of choice is the bilamellar tarsal rotation, in which a full-thickness incision is made through the scarred tarsal plate and the distal segment is rotated outward to redirect the lashes away from the cornea. This is a relatively simple procedure that can be performed by trained non-physician health workers in the field. Without surgery, trichiasis leads to progressive corneal abrasion, ulceration, and blindness. Epilation (manual removal of offending lashes) is a temporizing measure but not definitive, as lashes regrow.

Antibiotics target active infection (stages TF and TI). Oral azithromycin is preferred because it is given as a single dose (20 mg/kg in children, 1 g in adults), making it ideal for mass drug administration campaigns. In endemic communities, the entire population may be treated annually for 3-5 years to reduce the reservoir of infection. The alternative is topical tetracycline 1% ointment applied twice daily for 6 weeks, but adherence is far lower.

Facial cleanliness and environmental improvement are the prevention components. Transmission occurs through direct contact with ocular or nasal secretions, fomites (shared towels, bedding), and mechanical vector transfer by flies that breed in human feces and are attracted to facial discharge. Improving water access for face-washing, constructing latrines to reduce fly breeding sites, and reducing household overcrowding are all essential.

Regarding contraindications: azithromycin should be used cautiously in patients with hepatic impairment. In children under 6 months of age, topical tetracycline is preferred over systemic azithromycin.

5. Differential Diagnosis and Distractors

Differential Diagnosis	Why It Looks Similar	Key Discriminator
Inclusion conjunctivitis (adult chlamydial conjunctivitis)	Also caused by C. trachomatis with follicular conjunctivitis	Caused by serotypes D-K (urogenital serotypes); affects sexually active adults; follicles predominate on the lower tarsal conjunctiva; does not cause cicatricial complications or blindness
Adenoviral keratoconjunctivitis	Follicular conjunctivitis with red eye and discharge	Acute onset, often bilateral with preauricular lymphadenopathy; self-limited course over 2-3 weeks; no tarsal scarring; subepithelial corneal infiltrates rather than pannus
Vernal keratoconjunctivitis	Papillary hypertrophy on the upper tarsal conjunctiva	Allergic etiology with seasonal recurrence; giant (cobblestone) papillae, not follicles; associated with atopy, asthma, eczema; eosinophils on conjunctival scraping
Gonococcal ophthalmia neonatorum	Severe purulent conjunctivitis in a child from a resource-limited setting	Hyperacute onset with profuse purulent discharge in a neonate (days 2-5 of life); gram-negative intracellular diplococci on Gram stain; requires urgent parenteral ceftriaxone
Chlamydial ophthalmia neonatorum	C. trachomatis conjunctivitis in a child	Presents at 5-14 days of life (later than gonococcal); watery to mucopurulent discharge; no follicles (neonatal conjunctiva lacks lymphoid tissue to form follicles); treated with oral erythromycin for 14 days
Sarcoidosis (ocular)	Chronic granulomatous conjunctivitis with follicle-like nodules	Noncaseating granulomas; bilateral hilar lymphadenopathy on chest X-ray; elevated ACE levels; systemic multiorgan involvement

The single most important discriminator in a vignette is the location of follicles. Trachoma characteristically produces follicles on the upper tarsal conjunctiva, whereas adult inclusion conjunctivitis predominantly involves the lower fornix and lower tarsal conjunctiva. This anatomic distinction is a reliable way to differentiate the two chlamydial eye diseases.

6. Traps and High-Yield Pearls

The most common trap with trachoma questions is confusing the serotypes. Students frequently mix up the chlamydial serotypes: A-C cause trachoma (ocular), D-K cause urogenital disease and inclusion conjunctivitis, and L1-L3 cause lymphogranuloma venereum. A vignette describing follicular conjunctivitis in a sexually active adult with concurrent urethritis is inclusion conjunctivitis (D-K), not trachoma, even though both are caused by the same organism.

Another frequent mistake is thinking that a single episode of chlamydial conjunctivitis causes blindness. Trachoma-related blindness requires years of repeated reinfection and is a disease of cumulative scarring. If a vignette presents a child with a single episode of follicular conjunctivitis, the concern is treatment and prevention of reinfection, not imminent visual loss.

Students also commonly forget that trachoma is the leading infectious cause of preventable blindness worldwide. This phrase appears frequently in question stems and should immediately trigger recognition.

When a question asks about treatment, the expected answer is almost always oral azithromycin (single dose) rather than topical therapy, because single-dose treatment is the pillar of mass drug administration programs. However, if the question stem mentions trichiasis or eyelash-cornea contact, the answer shifts to surgical correction (bilamellar tarsal rotation) as the next best step, because antibiotics alone will not reverse structural scarring.

Finally, remember the mnemonic embedded in the SAFE strategy itself: the components are tested in order of clinical urgency. Surgery addresses the immediate threat to vision (trichiasis), antibiotics treat the active infection, and facial cleanliness plus environmental improvement prevent future transmission. The core competency being tested is the ability to match the correct intervention to the correct stage of disease.

1e:["$","$L2d",null,{"article":{"id":"4d4de1c0-a68a-4ad2-8901-8f496187472d","title":"Konjungtivitis Trakoma","content":"$2e","category":"Oftalmologi","created_at":"2026-05-13T06:32:47.728771+00:00","status":"published","subcategory":null},"questionCount":3,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]